Literature DB >> 29180549

Family Physicians' Perceived Prevalence, Safety, and Screening for Cigarettes, Marijuana, and Electronic-Nicotine Delivery Systems (ENDS) Use during Pregnancy.

Thomas F Northrup1, Michelle R Klawans2, Yolanda R Villarreal2, Adi Abramovici2, Melissa A Suter2, Joan M Mastrobattista2, Carlos A Moreno2, Kjersti M Aagaard2, Angela L Stotts2.   

Abstract

OBJECTIVE: Assess perceptions of prevalence, safety, and screening practices for cigarettes and secondhand smoke exposure (SHSe), marijuana (and synthetic marijuana), electronic nicotine delivery systems (ENDS; eg, e-cigarettes), nicotine-replacement therapy (NRT), and smoking-cessation medications during pregnancy, among primary care physicians (PCPs) providing obstetric care.
METHODS: A web-based, cross-sectional survey was e-mailed to 3750 US physicians (belonging to organizations within the Council of Academic Family Medicine Educational Research Alliance). Several research groups' questions were included in the survey. Only physicians who reported providing "labor and delivery" obstetric care responded to questions related to the study objectives.
RESULTS: A total of 1248 physicians (of 3750) responded (33.3%) and 417 reported providing labor and delivery obstetric care. Obstetric providers (N = 417) reported cigarette (54%), marijuana (49%), and ENDS use (24%) by "Some (6% to 25%)" pregnant women, with 37% endorsing that "Very Few (1% to 5%)" pregnant women used ENDS. Providers most often selected that very few pregnant women used NRT (45%), cessation medications (ie, bupropion or varenicline; 37%), and synthetic marijuana (23%). Significant proportions chose "Do not Know" for synthetic marijuana (58%) and ENDS (27%). Over 90% of the sample perceived that use of or exposure to cigarettes (99%), synthetic marijuana (99%), SHS (97%), marijuana (92%), or ENDS (91%) were unsafe during pregnancy, with the exception of NRT (44%). Providers most consistently screened for cigarette (85%) and marijuana use (63%), followed by SHSe in the home (48%), and ENDS (33%) and synthetic marijuana use (28%). Fewer than a quarter (18%) screened consistently for all substances and SHSe. One third (32%) reported laboratory testing for marijuana and 3% reported laboratory testing for smoking status.
CONCLUSION: This sample of PCPs providing obstetric care within academic settings perceived cigarettes, marijuana, and ENDS use to be prevalent and unsafe during pregnancy. Opportunities for increased screening during pregnancy across these substances were apparent. © Copyright 2017 by the American Board of Family Medicine.

Entities:  

Keywords:  Electronic Cigarettes; Family Physicians; Marijuana; Maternal Health; Obstetrics; Pregnancy; Primary Health Care; Screening; Tobacco Products

Mesh:

Substances:

Year:  2017        PMID: 29180549      PMCID: PMC5749232          DOI: 10.3122/jabfm.2017.06.170183

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  41 in total

Review 1.  E-cigarettes: Safe to recommend to patients?

Authors:  Jason M Jerry; Gregory B Collins; David Streem
Journal:  Cleve Clin J Med       Date:  2015-08       Impact factor: 2.321

2.  CAFM Educational Research Alliance (CERA) 2011 Residency Director survey: background, methods, and respondent characteristics.

Authors:  Arch G Mainous; Dean Seehusen; Navkiran Shokar
Journal:  Fam Med       Date:  2012 Nov-Dec       Impact factor: 1.756

3.  Colorado family physicians' attitudes toward medical marijuana.

Authors:  Elin Kondrad; Alfred Reid
Journal:  J Am Board Fam Med       Date:  2013 Jan-Feb       Impact factor: 2.657

4.  Benefits of smoking bans on preterm and early-term births: a natural experimental design in Switzerland.

Authors:  Ana M Vicedo-Cabrera; Christian Schindler; Dragana Radovanovic; Leticia Grize; Fabienne Witassek; Julia Dratva; Martin Röösli; Laura Perez
Journal:  Tob Control       Date:  2016-04-26       Impact factor: 7.552

5.  Prevalence and correlates of electronic-cigarette use in young adults: findings from three studies over five years.

Authors:  Danielle E Ramo; Kelly C Young-Wolff; Judith J Prochaska
Journal:  Addict Behav       Date:  2014-10-23       Impact factor: 3.913

6.  Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries.

Authors:  Mattias Oberg; Maritta S Jaakkola; Alistair Woodward; Armando Peruga; Annette Prüss-Ustün
Journal:  Lancet       Date:  2011-01-08       Impact factor: 79.321

7.  Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence.

Authors:  Magdalena Cerdá; Melanie Wall; Katherine M Keyes; Sandro Galea; Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2011-11-17       Impact factor: 4.492

8.  Tobacco Use Among Middle and High School Students--United States, 2011-2015.

Authors:  Tushar Singh; René A Arrazola; Catherine G Corey; Corinne G Husten; Linda J Neff; David M Homa; Brian A King
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-04-15       Impact factor: 17.586

9.  Impact of a stepwise introduction of smoke-free legislation on the rate of preterm births: analysis of routinely collected birth data.

Authors:  Bianca Cox; Evelyne Martens; Benoit Nemery; Jaco Vangronsveld; Tim S Nawrot
Journal:  BMJ       Date:  2013-02-14

Review 10.  Maternal smoking and infant feeding: breastfeeding is better and safer.

Authors:  Jose G Dorea
Journal:  Matern Child Health J       Date:  2007-01-17
View more
  8 in total

Review 1.  Electronic nicotine delivery systems and pregnancy: Recent research on perceptions, cessation, and toxicant delivery.

Authors:  Alison Breland; Andrea McCubbin; Kristin Ashford
Journal:  Birth Defects Res       Date:  2019-07-31       Impact factor: 2.344

2.  The impact of tobacco chemicals and nicotine on placental development.

Authors:  Melissa A Suter; Kjersti M Aagaard
Journal:  Prenat Diagn       Date:  2020-02-11       Impact factor: 3.050

Review 3.  Smoking and pregnancy: The era of electronic nicotine delivery systems.

Authors:  Nikita Desai
Journal:  Obstet Med       Date:  2020-01-21

4.  Clinician responses to cannabis use during pregnancy and lactation: a systematic review and integrative mixed-methods research synthesis.

Authors:  Janelle Panday; Shipra Taneja; Anuoluwa Popoola; Rachael Pack; Devon Greyson; Sarah D McDonald; Morgan Black; Beth Murray-Davis; Elizabeth Darling; Meredith Vanstone
Journal:  Fam Pract       Date:  2022-05-28       Impact factor: 2.290

Review 5.  Alterations of Mitochondrial Network by Cigarette Smoking and E-Cigarette Vaping.

Authors:  Manasa Kanithi; Sunil Junapudi; Syed Islamuddin Shah; Alavala Matta Reddy; Ghanim Ullah; Bojjibabu Chidipi
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

6.  Communication Between US Physicians and Patients Regarding Electronic Cigarette Use.

Authors:  Cristine D Delnevo; Michelle Jeong; Arjun Teotia; Michelle M Bover Manderski; Binu Singh; Mary Hrywna; Olivia A Wackowski; Michael B Steinberg
Journal:  JAMA Netw Open       Date:  2022-04-01

7.  Attitudes to E-Cigarettes and Cessation Support for Pregnant Women from English Stop Smoking Services: A Mixed Methods Study.

Authors:  Sue Cooper; Sophie Orton; Katarzyna A Campbell; Michael Ussher; Naomi Coleman-Haynes; Rachel Whitemore; Anne Dickinson; Andy McEwen; Sarah Lewis; Felix Naughton; Katharine Bowker; Lesley Sinclair; Linda Bauld; Tim Coleman
Journal:  Int J Environ Res Public Health       Date:  2019-01-03       Impact factor: 3.390

Review 8.  The use of electronic nicotine delivery systems during pregnancy and the reproductive outcomes: A systematic review of the literature.

Authors:  Victor M Cardenas; Lori A Fischbach; Parimal Chowdhury
Journal:  Tob Induc Dis       Date:  2019-07-01       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.